During the past decade, Watson Clinic Center For Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Watson Clinic Center For Research" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott" with 1 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Baim Institute for Clinical Research" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Watson Clinic Center For Research" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Watson Clinic Center For Research" are "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Watson Clinic Center For Research" in a lesser frequency.

Most popular intervention types in "Watson Clinic Center For Research" are "Drug" (8 trials), "Device" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Watson Clinic Center For Research" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Watson Clinic Center For Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Watson Clinic Center For Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Watson Clinic Center For Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".